Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / ORD SHS
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
12,840,897
-
Shares change
-
-1,129,283
-
Total reported value, excl. options
-
$499,509,000
-
Value change
-
+$13,572,823
-
Put/Call ratio
-
148%
-
Number of buys
-
64
-
Number of sells
-
50
-
Price
-
$38.90
Institutional Holders of NEURODERM LTD - ORD SHS as of Q3 2017
As of 30 Sep 2017 NEURODERM LTD - ORD SHS had 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,840,897 shares of stock of the company.
Largest 10 holders included CNH PARTNERS LLC, Sandell Asset Management Corp., OMNI PARTNERS LLP, JPMORGAN CHASE & CO, OxFORD Asset Management LLP, BAKER BROS. ADVISORS LP, Allianz Asset Management GmbH, City Financial Investment Co Ltd, WATER ISLAND CAPITAL LLC, and Vivaldi Asset Management, LLC.
This table shows 127 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.